About

Bas van Buijtenen is a Business Executive and Non-Executive Board Member who has devoted his career to growing businesses in drug delivery, health & nutrition, pharma packaging and (specialty) materials. In 2020, he joined LTS Lohmann Therapie-Systeme AG as Chief Executive Officer and Chairman of the Executive Board to drive the development and execution of its corporate strategy, building on LTS’s impressive track record as a leader in transdermal and transmucosal drug delivery.

Contributions

WEARABLES

EXTENDING PATIENT-FRIENDLY DRUG DELIVERY TO HIGH-VOLUME WEARABLE DEVICES

Iris Schnitzler discusses the benefits of on-body delivery systems, including the flexibility and convenience they bring to patients managing chronic conditions, and how the Sorrel platform overcomes some of the inherent complexities and challenges of developing such a device. Dr Schnitzler then goes on to speak with Bas van Buijtenen and Andrei Yosef about the Sorrel platform and how its integration within LTS supports the company’s fundamental objectives of enabling partners and empowering patients.